Production of high-lysine-content biscuit and examination of the absorption of lysine in humans

[1] S. J. Algert, N. E. Stubblefield, B. J. Grasse, Assessment of dietary-intake of lysine and arginine in patients with herpes-simplex. Journal of the American Dietetic Association, 87, 11. (1987) 1560–1561.10.1016/S0002-8223(21)03361-7Search in Google Scholar

[2] E. Armstrong, J. Elenbaas, Lysine for herpes-simplex virus. Drug Intelligence & Clinical Pharmacy, 17, 3. (1983) 186–186.10.1177/106002808301700303Open DOISearch in Google Scholar

[3] E. Ayala, D. Krikorian, Effect of L-lysine monohydrochloride on cutaneous herpes-simplex virus in the guinea-pig. Journal of Medical Virology, 28, 1. (1989) 16–20.10.1002/jmv.18902801052542441Open DOISearch in Google Scholar

[4] L. Benmohamed, I. Bettahi, X. Zhang, Protective immunity against ocular herpes simplex virus infection by immunization with glycoprotein D epitopes extended by n-epsilon-palmitoyl-lysine moiety that stimulate maturation of dendritic cells. Investigative Ophthalmology & Visual Science, 46. (2005) 1027.Search in Google Scholar

[5] J. Csapó, Zs. Csapóné Kiss, Élelmiszerkémia [Food chemistry]. Mezőgazda Kiadó. Budapest, 2004.Search in Google Scholar

[6] J. Csapó, Zs. Csapóné Kiss, Biokémia – állattenyésztőknek [Biochemistry for animal breeders]. Mezőgazda Kiadó. Budapest, 2007.Search in Google Scholar

[7] J. J. Digiovanna, H. Blank, Failure of lysine in frequently recurrent herpes-simplex infection. Treatment and Prophylaxis Archives of Dermatology, 120, 1. (1984) 48–51.10.1001/archderm.120.1.48Search in Google Scholar

[8] J. J. Digiovanna, M. N. Wesley, H. Blank, Failure of lysine in frequently recurrent herpes-simplex infection. Archives of Dermatology, 121, 2. (1985) 167–168.10.1001/archderm.121.2.167Search in Google Scholar

[9] A. M. Duncan, R. O. Ball, P. B. Pencharz, Lysine requirement of adult males is not affected by decreasing dietary protein. American Journal of Clinical Nutrition, 64. (1996) 718–725.10.1093/ajcn/64.5.7188901791Search in Google Scholar

[10] C. E. Ferroli, C. SerVaas, C. Kagan, Treatment of herpes simplex type 1 infections with the amino acid L-lysine is overlooked. Journal of American Dietetic Association, 96, 9. (1996) 1. A106.Search in Google Scholar

[11] N. W. Flodin, The metabolic roles, pharmacology, and toxicology of lysine. Journal of the American College of Nutrition, 1. (1997) 7–21.10.1080/07315724.1997.107186449013429Search in Google Scholar

[12] R. S. Griffith, D. C. Delong, J. D. Nelson, Relation of arginine-lysine antagonism to herpes-simplex growth in tissue-culture. Chemotherapy, 27, 3. (1981) 209–213.10.1159/0002379796262023Open DOISearch in Google Scholar

[13] R. S. Griffith, A. L. Norins, C. Kagan, Multicentered study of lysine therapy in herpes-simplex infection. Dermatologica, 156, 5. (1978) 257–267.10.1159/000250926640102Search in Google Scholar

[14] R. S. Griffith, D. E. Walsh, K. H. Myrmel, Success of L-lysine therapy in frequently recurrent herpes-simplex infection. Treatment and Prophylaxis Dermatologica, 175, 4. (1987) 183–190.10.1159/000248823Search in Google Scholar

[15] C. Ishihara, J. Iida, N. Mizukoshi, Effect of n-alpha-acetylmuramyl-L-alanyl-d-isoglutaminyl-n-epsilon-stearoyl-L-lysine on resistance to herpes-simplex virus type-1 infection in cyclophosphamide-treated mice. Vaccine, 7, 4. (1989) 309–313.10.1016/0264-410X(89)90191-6Search in Google Scholar

[16] C. Kagan, Lysine therapy for herpes simplex. The Lancet, (1974) 303. 7848. 137.Search in Google Scholar

[17] C. Kagan, Effect of acyclovir, bromovinyldeoxyuridine, vidarabine, and L-lysine on latent ganglionic herpes-simplex virus in vitro – additional comment. American Journal of Medicine, 75, 4. (1983) 59.10.1016/0002-9343(83)90447-3Open DOISearch in Google Scholar

[18] J. H. Luo, L. Aurelian, The transmembrane helical segment but not the invariant lysine is required for the kinase-activity of the large subunit of herpes-simplex virus type-2 ribonucleotide reductase (icp10). Journal of Biological Chemistry, 267, 14. (1992) 9645–9653.10.1016/S0021-9258(19)50139-9Search in Google Scholar

[19] J. Masterson, Lysine, herpes, schizophrenia and MCTD – a confirmation of the viral theory of schizophrenia from a longitudinal-study. Journal of Orthomolecular Medicine, 1, 2. (1986) 97–109.Search in Google Scholar

[20] M. A. McCune, H. O. Perry, S. A. Muller, Treatment of recurrent herpes-simplex infections with L-lysine monohydrochloride. Cutis, 34, 4. (1984) 366–373.Search in Google Scholar

[21] C. N. Meredith, Z. M. Wen, D. M. Bier, Lysine kinetics at graded lysine intakes in young man. American Journal of Clinical Nutrition, 43. (1986) 787–794.10.1093/ajcn/43.5.787Search in Google Scholar

[22] N. Milman, J. Scheibel, O. Jessen, Lysine prophylaxis in recurrent herpes-simplex labialis – double-blind, controlled crossover study. Acta Dermato-venereologica, 60, 1. (1980) 85–87.10.2340/00015555608587Search in Google Scholar

[23] N. Milman, J. Scheibel, O. Jessen, Failure of lysine treatment in recurrent herpes-simplex labialis. Lancet, 2. 8096. (1987) 942–942.10.1016/S0140-6736(78)91658-6Search in Google Scholar

[24] N. H. Park, D. Pavanlangston, E. Declercq, Effect of acyclovir, bromovinyldeoxyuridine, vidarabine, and L-lysine on latent ganglionic herpes-simplex virus in vitro. American Journal of Medicine, 73, 1a. (1982) 151–154.10.1016/0002-9343(82)90081-XSearch in Google Scholar

[25] K. T. Richardson, D. C. Pearson. Unit dosage forms for the treatment of herpes simplex. United States Patent 6,632,445. October 14. 2003.Search in Google Scholar

[26] W. T. Ruyechan, J. W. Olson, Surface lysine and tyrosine residues are required for interaction of the major herpes-simplex virus type-1 DNA-binding protein with single-stranded-DNA. Journal of Virology, 66, 11. (1992) 6273–6279.10.1128/jvi.66.11.6273-6279.1992Search in Google Scholar

[27] C. A. Simon, G. D. Vanmelle, A. A. Ramelet, Failure of lysine in frequently recurrent herpes-simplex infection. Archives of Dermatology, 121, 2. (1985) 167–167.10.1001/archderm.1985.01660020025001Search in Google Scholar

[28] I. P. Smirnova, S. B. Alekseev, S. V. Diorditsa, Effect of L-lysine-a-oxidase on the development of genital herpes infection in guinea pigs. Bulletin of Experimental Biology and Medicine, 128, 12. (1999) 1226–1228.10.1007/BF02434824Search in Google Scholar

[29] D. J. Thein, W. C. Hurt, Lysine as a prophylactic agent in the treatment of recurrent herpes-simplex labialis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics, 58, 6. (1984) 659–666.10.1016/0030-4220(84)90030-6Open DOISearch in Google Scholar

[30] F. A. Tomblin, K. H. Lucas, Lysine for management of herpes labialis. American Journal of Health-system Pharmacy, 58, 4. (2001) 298.10.1093/ajhp/58.4.29811225166Search in Google Scholar

[31] Y. Toride, Lysine and other amino acids for feed: production and contribution to protein utilization in animal feeding. Protein source for the animal feed industry. FAO Corporate Document Repository, 04.24.2007.Search in Google Scholar

[32] D. E. Walsh, R. S. Griffith, A. Behforooz, A subjective response to lysine in the therapy of herpes-simplex. Journal of Antimicrobial Chemotherapy, 12, 5. (1983) 489–496.10.1093/jac/12.5.4896423612Open DOISearch in Google Scholar